ESMO Sarcoma & GIST Symposium 2022
The ESMO Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types.
The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities. The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.
Produced by the European Society for Medical Oncology
http://www.esmo.org
Видео ESMO Sarcoma & GIST Symposium 2022 канала European Society for Medical Oncology (ESMO)
The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities. The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.
Produced by the European Society for Medical Oncology
http://www.esmo.org
Видео ESMO Sarcoma & GIST Symposium 2022 канала European Society for Medical Oncology (ESMO)
Показать
Комментарии отсутствуют
Информация о видео
14 января 2022 г. 20:32:18
00:01:41
Другие видео канала
![Expert Report on latest data in the management of metastatic prostate cancer from ASCO 2022](https://i.ytimg.com/vi/IanQNNBfFes/default.jpg)
![OncologyPRO, a 360 research solution designed around you](https://i.ytimg.com/vi/wqzz-57VS70/default.jpg)
![AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber](https://i.ytimg.com/vi/b3b9bg4TSuQ/default.jpg)
![Essentials in bioinformatics and systems biology for oncologists](https://i.ytimg.com/vi/EJjdNVlOtmg/default.jpg)
![ESMO Clinical Unit Visit](https://i.ytimg.com/vi/tXWwr2WQ6XI/default.jpg)
![Supportive care in the context of precision cancer medicine](https://i.ytimg.com/vi/c_XV2lz8V3g/default.jpg)
![Gender Medicine in Oncology - An ESMO Initiative](https://i.ytimg.com/vi/_R77hOzg9io/default.jpg)
![#ESMO21 Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer (FRAME)](https://i.ytimg.com/vi/l2I0kIcTaxE/default.jpg)
![Expert Video Report on therapeutic advances in NSCLC from 2021 ASCO Annual Meeting](https://i.ytimg.com/vi/mRhBpXM0mqA/default.jpg)
![ESMO Recommendations for Use of Tumour Multigene NGS in Metastatic Cancers](https://i.ytimg.com/vi/9GL8XvwGySU/default.jpg)
![How Can Cancer Affect Bone Health](https://i.ytimg.com/vi/2x7MURPFGks/default.jpg)
![Personalised medicine: The impact in elderly patients with cancer](https://i.ytimg.com/vi/I4l2nUPUXWA/default.jpg)
![#ESMO23 Head and neck cancer Track highlights with Chair Paolo Bossi](https://i.ytimg.com/vi/Q6IAr7wxO30/default.jpg)
![#ESMO21 Expert Video Report on colorectal cancer](https://i.ytimg.com/vi/zLW6iA1WylM/default.jpg)
![Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022](https://i.ytimg.com/vi/5w4ffWSnltQ/default.jpg)
![#ESMO23 Genitourinary tumours (non-prostate) Track highlights with Chair Michiel van der Heijden](https://i.ytimg.com/vi/8l7tfkgolLo/default.jpg)
![How to select patients with localised soft tissue sarcoma for neoadjuvant/adjuvant chemotherapy?](https://i.ytimg.com/vi/BKBjen9nN2w/default.jpg)
![ESMO OncologyPRO - Intro by Prof. A. MATIKAS](https://i.ytimg.com/vi/vRDxdzlbfek/default.jpg)
![Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021](https://i.ytimg.com/vi/3IqbWbSF4_E/default.jpg)
![Silke Gillessen: Translational research to clinical practice, #ESMO23 to cater for every oncologist](https://i.ytimg.com/vi/mqQYG1m1TRU/default.jpg)
![ESMO 2019 Daily Reporter - Editor's Picks: Ovarian cancer](https://i.ytimg.com/vi/kNi4bEVu8XI/default.jpg)